Form 4: Vivani Medical Director and 10% Owner Gregg Williams Reports New Stock Option Grant and Clerical Correction

Vivani Medical, Inc. Director and 10% Owner Gregg Williams filed a Form 4 detailing the acquisition of new non-qualified stock options and a clerical adjustment to a previously reported option grant.

Summary

• Gregg Williams, a Director and 10% Owner of Vivani Medical, Inc. (VANI), filed a Form 4, a Statement of Changes in Beneficial Ownership.
• The filing reports the acquisition of 35,135 non-qualified stock options with an exercise price of $1.27, granted on June 24, 2025, as an annual grant pursuant to the Issuer's Non-Employee Director Compensation Policy.
• These newly acquired options will vest in total on the earlier of the first anniversary of the grant (June 24, 2026) or the next annual meeting of stockholders, subject to continued service through such date.
• The filing also includes an adjustment to a previously reported non-qualified stock option grant from January 1, 2025, correcting the amount from 76,757 to 76,393 due to a clerical error, effectively reducing the reported amount by 364 options.
• The adjusted option amount of 76,393 has an exercise price of $1.16 and vests one-fourth at the end of each calendar quarter following the grant date, subject to continued service.
• Following these transactions, Gregg Williams beneficially owns 35,135 options exercisable at $1.27 and 76,393 options exercisable at $1.16, totaling 111,528 derivative securities.

Sentiment

Score: 7

Explanation: The acquisition of new stock options by a director and 10% owner is generally viewed positively as it aligns their interests with shareholders. The clerical error is a minor, neutral event that has been corrected.

Positives

• The acquisition of 35,135 new non-qualified stock options by a Director and 10% Owner indicates continued alignment of interests with shareholders and confidence in the company's future.

Negatives

• A clerical error required an adjustment to a previously reported option grant, though the impact is minor (364 options) and has been corrected.

Future Outlook

The document primarily reports past and current insider transactions and does not provide forward-looking statements or guidance regarding the company's future performance or strategic direction, beyond the vesting schedules of the granted options.

Management Comments

• The filing notes that the 35,135 options were an 'Annual grant awarded pursuant to the Issuer's Non-Employee Director Compensation Policy.'
• It also clarifies that the adjustment of 364 options was 'due to a clerical error.'

Industry Context

This Form 4 filing is a routine disclosure of insider trading activity, specifically an equity grant to a director. Such grants are common practice in the biotechnology and medical device industries, aligning executive and director incentives with shareholder value creation. It does not provide broader industry trends or competitive analysis.

Comparison to Industry Standards

• The document does not provide sufficient information to compare Vivani Medical's performance or compensation practices to specific comparable companies or industry benchmarks. It is a standard disclosure of an individual's equity transactions, which are common forms of executive and director compensation across industries.

Corporate Governance

Stakeholder Impact

• Shareholders: The grant of stock options to a director and 10% owner aligns their financial interests with those of the shareholders, potentially encouraging decisions that enhance shareholder value.

Next Steps

• The 35,135 non-qualified stock options will vest on the earlier of the first anniversary of the grant (June 24, 2026) or the next annual meeting of stockholders, subject to continued service.
• The 76,393 non-qualified stock options will continue to vest one-fourth at the end of each calendar quarter following their original grant date of January 1, 2025, subject to continued service.

Key Dates

Keywords

Vivani Medical, VANI, SEC Form 4, Insider Trading, Stock Options, Director Compensation, Gregg Williams, Beneficial Ownership, Equity Grant